China Biotech Services further delays circular on PHC Medical Diagnostic Centre and Premier Medicare disposal

Bulletin Express

Jun 26

China Biotech Services Holdings Limited announced a second postponement in issuing the shareholder circular for its proposed disposal of the entire issued share capital in PHC Medical Diagnostic Centre Limited and Premier Medicare Services Limited.

The board disclosed that the company had previously secured a waiver from the Hong Kong Stock Exchange’s GEM Listing Rule 19.41(a), allowing dispatch of the circular no later than 26 June 2026. As additional time is required to finalise information for inclusion, a new waiver application has been submitted. A revised dispatch timetable will be released once regulatory feedback is received.

The transaction was first disclosed on 18 May 2026, with a follow-up announcement on 2 June 2026, and an initial delay notice on 9 June 2026. No changes to deal terms or consideration were reported in the latest filing.

Board composition remains unchanged, comprising three executive directors—Chairman Liu Xiaolin, Dr. Huang Song and Dr. Yin Ye—and three independent non-executive directors—Mr. Yan Guoxiang, Dr. Guo Yuantao and Dr. Zhang Xiao.

The announcement was released in Hong Kong on 26 June 2026. All information has been confirmed by the directors as accurate and complete in all material respects.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/1120382776"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120382776\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120382776?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-26 21:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120382776","market":"us","top_or_hot":-1,"title":"China Biotech Services further delays circular on PHC Medical Diagnostic Centre and Premier Medicare disposal","media":"Bulletin Express","content":"<p>China Biotech Services Holdings Limited announced a second postponement in issuing the shareholder circular for its proposed disposal of the entire issued share capital in PHC Medical Diagnostic Centre Limited and Premier Medicare Services Limited.</p>\n<p>The board disclosed that the company had previously secured a waiver from the Hong Kong Stock Exchange’s GEM Listing Rule 19.41(a), allowing dispatch of the circular no later than 26 June 2026. As additional time is required to finalise information for inclusion, a new waiver application has been submitted. A revised dispatch timetable will be released once regulatory feedback is received.</p>\n<p>The transaction was first disclosed on 18 May 2026, with a follow-up announcement on 2 June 2026, and an initial delay notice on 9 June 2026. No changes to deal terms or consideration were reported in the latest filing.</p>\n<p>Board composition remains unchanged, comprising three executive directors—Chairman Liu Xiaolin, Dr. Huang Song and Dr. Yin Ye—and three independent non-executive directors—Mr. Yan Guoxiang, Dr. Guo Yuantao and Dr. Zhang Xiao.</p>\n<p>The announcement was released in Hong Kong on 26 June 2026. All information has been confirmed by the directors as accurate and complete in all material respects.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Biotech Services further delays circular on PHC Medical Diagnostic Centre and Premier Medicare disposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Biotech Services further delays circular on PHC Medical Diagnostic Centre and Premier Medicare disposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-26 21:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Biotech Services Holdings Limited announced a second postponement in issuing the shareholder circular for its proposed disposal of the entire issued share capital in PHC Medical Diagnostic Centre Limited and Premier Medicare Services Limited.</p>\n<p>The board disclosed that the company had previously secured a waiver from the Hong Kong Stock Exchange’s GEM Listing Rule 19.41(a), allowing dispatch of the circular no later than 26 June 2026. As additional time is required to finalise information for inclusion, a new waiver application has been submitted. A revised dispatch timetable will be released once regulatory feedback is received.</p>\n<p>The transaction was first disclosed on 18 May 2026, with a follow-up announcement on 2 June 2026, and an initial delay notice on 9 June 2026. No changes to deal terms or consideration were reported in the latest filing.</p>\n<p>Board composition remains unchanged, comprising three executive directors—Chairman Liu Xiaolin, Dr. Huang Song and Dr. Yin Ye—and three independent non-executive directors—Mr. Yan Guoxiang, Dr. Guo Yuantao and Dr. Zhang Xiao.</p>\n<p>The announcement was released in Hong Kong on 26 June 2026. All information has been confirmed by the directors as accurate and complete in all material respects.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"08037","symbol_name":"中国生物科技服务","start_time":0,"source_url":"","article_id":"1120382776","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120382776","pubTimestamp":1782481423,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Biotech Services Holdings Limited announced a second postponement in issuing the shareholder circular for its proposed disposal of the entire issued share capital in PHC Medical Diagnostic...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"08037":"中国生物科技服务"},"translate_title":"中国生物科技服务进一步延迟有关PHC医疗诊断中心及Premier Medicare处置的通告","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08037":1},"content_text":"China Biotech Services Holdings Limited announced a second postponement in issuing the shareholder circular for its proposed disposal of the entire issued share capital in PHC Medical Diagnostic Centre Limited and Premier Medicare Services Limited.\nThe board disclosed that the company had previously secured a waiver from the Hong Kong Stock Exchange’s GEM Listing Rule 19.41(a), allowing dispatch of the circular no later than 26 June 2026. As additional time is required to finalise information for inclusion, a new waiver application has been submitted. A revised dispatch timetable will be released once regulatory feedback is received.\nThe transaction was first disclosed on 18 May 2026, with a follow-up announcement on 2 June 2026, and an initial delay notice on 9 June 2026. No changes to deal terms or consideration were reported in the latest filing.\nBoard composition remains unchanged, comprising three executive directors—Chairman Liu Xiaolin, Dr. Huang Song and Dr. Yin Ye—and three independent non-executive directors—Mr. Yan Guoxiang, Dr. Guo Yuantao and Dr. Zhang Xiao.\nThe announcement was released in Hong Kong on 26 June 2026. All information has been confirmed by the directors as accurate and complete in all material respects.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}